Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by Investor62on Apr 15, 2020 5:14am
70 Views
Post# 30910423

RE:RE:RE:RE:RE:RE:RE:new video on twitter 56 mins ago

RE:RE:RE:RE:RE:RE:RE:new video on twitter 56 mins agosorry letdoit2 but really nothing intelligent comes from you in the last message.
Did you watch the video of Daryl and understand it? Of interest is hardly how many pies someone can eat.
For me the facts of Lexagene count. In contrast to most of the already authorized devices from larger companies, they can only test for COVID-19 and this with a lower reliability 70%. Due to the current situation, Lexagene has decided to work on an FDA approval earlier. This is not as easy for a small cap company as it is for the big companies (unless you do not believe Daryl's statement). The focus of Lexagene is still the vet and food testing, which are easier to achieve. However, Daryl is confident that they will receive FDA approval in Q2 and be ready for a second wave (which Dr. Jack Regan believes is possible in fall unfortunately).
In Q2 it is planned to position the first devices in hospitals. A sales team will also be hired and the production start is foreseen in Q3, 2020.
I don't know what BS was in this interview but that seems to be a matter of opinion.
For me comments like the your last one:
"what a load of BS, I said a while ago that all these NRs are just pure nonsense, glad to see Rebeck has at last got off his lazy fat ar $e, however, you're all missing the major issue here, just how many pies does he actually get through in a day? does anyone know?" is a real waste of time.
When you are so confident that Lexagene is a bad investmenty then sell the stocks and make your wise comments in another board – thank you
<< Previous
Bullboard Posts
Next >>